BroadOak Logo

Latest News

Updates on BroadOak investments, transactions, events, and industry news.

BioCare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization)

BroadOak partnered with United BioChannels (UBC) to acquire ORFLO Technologies (ORFLO) in October 2022. ORFLO, a

Flagship Biosciences hired industry veteran Tom Turi as Chief Scientific Officer. Tom will help grow the

BroadOak completed a growth equity investment in EmVenio Research, alongside members of the company’s management team

Following BroadOak’s growth equity investment in Flagship Biosciences, Flagship Biosciences has acquired Interpace Pharma Solutions, a

Halo Labs logo

BroadOak joined Agilent Technologies, a global leader in life sciences and diagnostics, to increase its investment

BroadOak invested in Microsize, a CDMO specializing in micronization and particle size control, as part of

BroadOak invested in Kemp Proteins, a leading CDMO specializing in the production of novel proteins. The

BroadOak Capital Partners advised Bioresource Technology (“BRT”) on the sale of the company to Medix Biochemica. 

It is an exciting time at BroadOak as we help advance innovative life sciences technologies.

Holly Atallah
Director of Finance & Operations

BroadOak Logo Only

Our Story

BroadOak has advised and invested in life sciences companies for over 15 years. Get to know us.